BTG Live Discussion

Live Discuss Polls Ratings Documents
Page

dave297 14 Nov 2017

Interims Solid enough statement & Ralph leaving unlikely to have any impact,particularly as his replacement has been with BTG for 3+ years

rikid 13 Nov 2017

Re: I repeat !!! Results tomorrow. Looks like it will be bad news although nothing that we don't already know. May be dropping back to the £5 mark before recovering next year, unless more skeletons fall out of the cupboard!

pauloverdi 13 Nov 2017

I repeat !!! "Does anybody know what's going on" ??!£7.72 down in a couple of weeks to this pathetic drop in share price !!!Paulo

up protherics 13 Nov 2017

Re: SHARE PRICE FALL AGAIN INMOIts down to the pantomime duo.. Hopefully they will be gone soon, but I wouldn't be surprised if they come out with some wonderful negative news to decimate any hope of a price rally before they go.I am amazed they didn't try to sell some stock before the collapse going by their past.

innocent 2 13 Nov 2017

SHARE PRICE FALL AGAIN I wonder what is causing the current fall in the share price; yet again?

up protherics 09 Nov 2017

Vistogard/Varithena INMOIt looks like BTG put their sales and marketing force into Varithena and completely disregarded Vistogard... If that's the case no wonder Wellstat took them to court.My question is why didn't they try to resolve this before litigation took place.. Very arrogant to say the least.What I cannot understand is that none of the major institutions holding this stock are not looking for answers. Unless of course they know of a possible bid for the company.

up protherics 09 Nov 2017

Re: ????? INMOApart from their usual ineptness of late something else might be going on.How about someone looking at possibly taking them over.. Hence why the price has been knocked back from 7.78.The bidder may have approached them indicating they might be interested in making an offer.So don't be surprised if we get an Rns saying a possible offer may materialise after due diligence is carried out.. I would imagine that the bidder will want to make a better job of their due diligence and be more thorough than BTG have ever been.My guess is that this will eventually go for about 15% up from where we are now.

pauloverdi 09 Nov 2017

????? To quote an apt amusing high pitched advert "DOES ANYBODY KNOW WHAT's GOING ON" ??

up protherics 06 Nov 2017

Pantomine The pantomime continues.Someone/somebodies have not been doing their job properly during the past 3 years INMOBiocompatibles fine due to lack of due diligenceFX lossWellstat fine and loss of marketing rightsVarithenaStill what is a 100 million off the bottom line.. Only equates to 30 odd million for the past 3 yearsI wonder what else is going to materialise during the coming months.

d gaser 03 Nov 2017

update on Lemrada sales are excellent I have taken this dater from todays update from Sanofi 3rd quarter sales, and Lemtrada is doing very nicely it's up 5.4% in just this quarter alone . BE HAPPYDAVE , Multiple Sclerosis franchise Net sales (€ million) Q3 2017 Change (CER) 9M 2017 Change (CER)Aubagio® 382 +19.2% 1,178 +26.9%---------- ---------- ---------- ---------- ---------- ---------- ---------Lemtrada® 113 +5.4% 362 +18.5%;---------- ---------- ---------- ---------- ---------- ---------- --------Total Multiple Sclerosis 495 +15.7% 1,540 +24.8%.---------- ---------- ---------- ---------- -------- Third-quarter Multiple Sclerosis (MS) sales grew 15.7% to €495 million, driven by Aubagio® performance in the U.S. and Europe. Year-to-date MS sales increased 24.8% to €1,540 million. Third-quarter Aubagio® sales increased 19.2% to €382 million driven by the U.S. (up 20.9% to €274 million). In Europe sales of Aubagio were up 16.0% to €86 million. Year-to-date Aubagio® sales increased 26.9% to €1,178 million. In the third quarter Lemtrada® sales were up 5.4% to €113 million, including €60 million in the U.S. (stable) and €40 million in Europe (up 10.8%). Year-to-date Lemtrada® sales increased 18.5% to €362 million.

oldjoe1 02 Nov 2017

BTG Interims 14th November........ BTG...pushing on up to Interims on the 14th Nov. EPS seen increasing 84% and P/E of 25 to 2018, (Hist Low)Numis have a 900p SP Target 😎😃 Massive volume yesterday. [link]

Mike Land 20 Oct 2017

Re: Enlightenment Great report. Good explanation as to why share price has recently picked up. I am amazed how thin the free float of shares is after you ignore the institutions and insider owners. Means we all need to sell before they do!!! And I guess it means they all want an offer for the company at some time at the right price.

oldjoe1 20 Oct 2017

Re: Enlightenment BTG Analysis.......[link]

Tricky Rich 18 Oct 2017

Re: BTG, Yearly Chart Breakout.......... Nothing to do with a chart, everything to do with information that Zytiga is performing better than expected and it will be receiving nice royalties. Information and newsflow moves prices not charts.

oldjoe1 18 Oct 2017

BTG, Yearly Chart Breakout.......... BTG Btg yearly and 6 month breakout. Brokers have been bullish recently. eg, 05 Oct 17 Numis Buy 741.00 900.00 900.00 Reiterates.Broker Upgrade ---17-Oct-2017 05:16:40 - BTG PLC BTG.L:JEFFERIES RAISES TARGET PRICE TO 900P FROM 775P;RATING BUY.

Page